---
title: "AI-Based Early Detection of Polycystic Ovary Syndrome Using Follicle Count and Machine Learning"
id: "medrxiv-0-ai-driven-early-detection-of-polycystic-ovary-syndrome-via-follicle-count"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-ai-driven-early-detection-of-polycystic-ovary-syndrome-via-follicle-count"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1?rss=1"
published_at: "2026-09-04T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# AI-Based Early Detection of Polycystic Ovary Syndrome Using Follicle Count and Machine Learning
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-ai-driven-early-detection-of-polycystic-ovary-syndrome-via-follicle-count
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1?rss=1)
- **Published At:** 2026-09-04T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study addresses underdiagnosis and delayed diagnosis of **Polycystic Ovary Syndrome** (PCOS) by developing machine learning models for early prediction using clinical data. - Researchers used a structured dataset of 542 patient records and 42 features, including anthropometrics, hormone levels, and **follicle count** among other clinical and symptom indicators. - Data preprocessing included cleaning, scaling/normalization, and correlation-based feature selection to retain the most predictive variables and prevent dominance by large-range features. - Multiple classification algorithms were trained and compared: Logistic Regression, Decision Tree, K-nearest neighbors (KNN), and **Random Forest**. - The Random Forest model delivered the best overall performance, with reported accuracy of approximately 88%, indicating ensemble models can capture non-linear interactions in clinical data. - The authors situate results alongside international clinical guidance and recent literature on explainable and clinically applicable PCOS prediction systems, emphasizing the need for clinical interpretability. - The dataset originates from a publicly distributed PCOS benchmarking dataset (542 records) with mixed continuous and categorical features, and the target label indicates PCOS status (Y/N). - The paper is a medRxiv preprint and has not undergone peer review; the authors note ethical approvals and participant consent were obtained and disclose no competing interests. - Data availability is described: the dataset includes BMI, hormone concentrations, follicle counts, symptom indicators (acne/hirsutism), cycle regularity, and lifestyle features obtained from a commonly used research dataset. - The study highlights potential for machine learning to support earlier identification of PCOS but does not provide peer-reviewed clinical practice recommendations; further validation and explainability work are implied as next steps.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=lbyst1Jlf7cHywblnMgTy0Pwwk5ZWOPNM_4W11KQJjM-1788537744.328846-1.2.1.1-tyft.Yk9lg0b87T9NuMNJbUjOLss8sG0TZQ969SeZkODVnA.q9tNMhx8PzucA.lk) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # AI-Driven Early Detection of Polycystic Ovary Syndrome via Follicle Count Divya Thota, Aishwarya Mahesha, Mohammed Fazil Khasim, Khyathi Priya Kethineni, Bhavana Pothireddygari, Bahareh Rahmani doi: https://doi.org/10.64898/2026.09.01.26361974 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Divya Thota 1 Saint Louis University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Divya%2BThota%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Thota%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADivya%2BThota%2B) Aishwarya Mahesha 1 Saint Louis University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Aishwarya%2BMahesha%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mahesha%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAishwarya%2BMahesha%2B) Mohammed Fazil Khasim 1 Saint Louis University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mohammed%2BFazil%2BKhasim%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Khasim%20MF&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMohammed%2BFazil%2BKhasim%2B) Khyathi Priya Kethineni 1 Saint Louis University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Khyathi%2BPriya%2BKethineni%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kethineni%20KP&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKhyathi%2BPriya%2BKethineni%2B) Bhavana Pothireddygari 1 Saint Louis University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Bhavana%2BPothireddygari%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pothireddygari%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABhavana%2BPothireddygari%2B) Bahareh Rahmani 2 University of Tulsa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Bahareh%2BRahmani%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rahmani%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABahareh%2BRahmani%2B) * For correspondence: bahareh.rahmani@gmail.com * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1292443/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1292443/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1292443/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1292443/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1292443/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Polycystic Ovary Syndrome is a common endocrine disorder characterized by ovulatory dysfunction, hyperandrogenism, and/or polycystic ovarian morphology, with significant reproductive and metabolic consequences. Due to heterogeneous symptom profiles, Polycystic Ovary Syndrome is frequently underdiagnosed or diagnosed late. In this study, we develop machine learning models for early Polycystic Ovary Syndrome prediction using a structured clinical dataset with 42 features and 542 patient records. After data cleaning and normalization, correlation-based feature selection was applied to retain the most predictive variables. Multiple models were trained and evaluated, including Logistic Regression, Decision Tree, KNN, and Random Forest. Results demonstrate that Random Forest achieves the best overall performance (approximately 88% accuracy), suggesting that ensemble models can effectively capture non-linear feature interactions in clinical data. We also contextualize findings with international clinical guidance and recent work on explainable and clinically applicable Polycystic Ovary Syndrome prediction systems. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The dataset used in this project is a structured Polycystic Ovary Syndrome dataset with 542 patient records and dozens of clinical/physical parameters (e.g., BMI, hormone levels, follicle counts) commonly distributed for research and benchmarking. The target label indicates Polycystic Ovary Syndrome status (Y/N). The features include a mixture of continuous variables (e.g., hormone concentrations, anthropometrics) and binary/categorical indicators (e.g., symptoms such as acne/hirsutism indicators, cycle regularity, lifestyle-related features). This mixture motivates preprocessing steps such as scaling/normalization and careful feature selection to ensure models are not dominated by variables with larger numeric ranges Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.07.21.26358398v2 "Nucleus basalis of Meynert integrity is associated with cognitive dysfunction in Parkinson's disease independently of locus coeruleus degeneration")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.01.26361969v1 "Established polygenic risk score for hypercholesterinemia demonstrates discriminatory value and risk stratification in an independent German Cohort") Posted September 04, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/04/2026.09.01.26361974.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.01.26361974v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/04/2026.09.01.26361974.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) AI-Driven Early Detection of Polycystic Ovary Syndrome via Follicle Count Divya Thota, Aishwarya Mahesha, Mohammed Fazil Khasim, Khyathi Priya Kethineni, Bhavana Pothireddygari, Bahareh Rahmani medRxiv 2026.09.01.26361974; doi: https://doi.org/10.64898/2026.09.01.26361974 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361974v1%26text%3DAI-Driven%2520Early%2520Detection%2520of%2520Polycystic%2520Ovary%2520Syndrome%2520via%2520Follicle%2520Count "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361974v1%26t%3DAI-Driven%2520Early%2520Detection%2520of%2520Polycystic%2520Ovary%2520Syndrome%2520via%2520Follicle%2520Count "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361974v1%26title%3DAI-Driven%2520Early%2520Detection%2520of%2520Polycystic%2520Ovary%2520Syndrome%2520via%2520Follicle%2520Count%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361974v1%26title%3DAI-Driven%2520Early%2520Detection%2520of%2520Polycystic%2520Ovary%2520Syndrome%2520via%2520Follicle%2520Count "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.01.26361974) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.01.26361974v1&count=horizontal&via=&text=AI-Driven%20Early%20Detection%20of%20Polycystic%20Ovary%20Syndrome%20via%20Follicle%20Count&counturl=www.medrxiv.org/content/10.64898/2026.09.01.26361974v1 "Tweet This") ## Subject Area * [Health Informatics ](https://www.medrxiv.org/collection/health-informatics) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (615) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (896) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (327) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4775) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (476) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (408) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (644) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1616) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15847) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1196) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6992) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1058) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4995) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1428) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1741) * [Hematology](https://www.medrxiv.org/collection/hematology) (583) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1337) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16247) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1162) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (664) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (151) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (721) * [Neurology](https://www.medrxiv.org/collection/neurology) (7205) * [Nursing](https://www.medrxiv.org/collection/nursing) (365) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1074) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1233) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1002) * [Oncology](https://www.medrxiv.org/collection/oncology) (3580) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1038) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (393) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (448) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (466) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (704) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1779) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (733) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (759) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5841) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9703) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2390) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1436) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1245) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (635) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (769) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (577) * [Surgery](https://www.medrxiv.org/collection/surgery) (768) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (303) * [Urology](https://www.medrxiv.org/collection/urology) (286) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this prep
## Related Clinical Research

- [Nonlinear association of sleep quality (PSQI) with type 2 diabetes prevalence in community chronic](https://medichelpline.com/clinical-feed/plos-one-18-nonlinear-relationship-between-sleep-quality-and-prevalence-of-type-2-diabetes.md)
- [GLP-1 receptor agonists and PMOS: evidence, mechanisms, and who may benefit](https://medichelpline.com/clinical-feed/medical-news-today-0-can-glp-1s-really-help-treat-pmos-experts-answer-3-key-questions.md)
- [N-glycome Profiling of Dried Blood Spots for Pre-diabetes and Diabetes Distinction](https://medichelpline.com/clinical-feed/biorxiv-0-n-glycome-analysis-of-dried-blood-spots-from-different-blood-preparations-and.md)
- [Housing Facility Differences in the Gut Microbiome Confound Arsenic Effects on Glucose Homeostasis](https://medichelpline.com/clinical-feed/biorxiv-1-home-is-where-the-heterogeneity-is-housing-facility-level-differences-in-the.md)
- [GLP-1 medications and temporary hair loss risk in type 2 diabetes](https://medichelpline.com/clinical-feed/medical-news-today-0-glp-1-drugs-linked-to-temporary-hair-loss-here-s-why.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.